However, it is postulated from preclinical data that incorporating GCG receptor agonism may reduce food intake and increase resting energy expenditure, potentially enhancing efficacy
This symptom tends to be more common in the early weeks of treatment
It allows that yerba mate's polyphenols may reduce inflammation markers and support hepatic insulin sensitivity, which indirectly benefits glucose handling, but it separates that from any GLP-1 secretion effect
Understanding what this combination actually does, how the two molecules interact, and whether the theoretical benefits translate into real-world outcomes requires looking past marketing claims and into the biochemistry
You must purchase from a vendor that explicitly sells for research use only and requires agreement to those terms
People seeking to treat a substance use disorder with GLP-1RAs face a massive barrier to entry, though: This treatment is still off-label, meaning insurance will not cover it